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Abstract 
Although childhood adversity (CA) increases risk for subsequent mental illnesses, 
developmental mechanisms underpinning this association remain unclear. The 
hypothalamic-pituitary-adrenal axis (HPAA) is one candidate system potentially linking 
CA with psychopathology. However, determining developmental effects of CA on 
HPAA output and differentiating these from effects of current illness has proven 
difficult. Different aspects of HPAA output are governed by differentiable physiological 
mechanisms. Disaggregating HPAA output according to its biological components 
(baseline tonic cortisol, background diurnal variation, phasic stress response) may 
improve precision of associations with CA and/or psychopathology. In a novel proof-of-
principle investigation we test whether different predictors, CA (distal risk factor) and 
current depressive symptoms, show distinct associations with dissociable HPAA 
components. A clinical group (aged 16-25) at high-risk for developing severe 
psychopathology (n=20) were compared to age and sex matched healthy controls 
(n=21). Cortisol was measured at waking (x4), following stress induction (x8), and 
during a time-environment-matched non-stress condition. Using piecewise multilevel 
modeling, stress responses were disaggregated into increase and decrease, while 
controlling for waking cortisol, background diurnal output and confounding variables. 
Elevated waking cortisol was specifically associated with higher CA scores. Higher 
non-stress cortisol was specifically associated with higher depressive scores. Following 
stress induction, depressive symptoms attenuated cortisol increase, whilst CA 
attenuated cortisol decrease. The results support a differential HPAA dysregulation 
hypothesis where physiologically dissociable components of HPAA output are 
differentially associated with distal (CA) or proximal (depressive symptoms) predictors. 
This proof-of-principle study demonstrates that future cortisol analyses need to 
disaggregate biologically independent mechanisms of HPAA output.  
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1. Introduction 
 
Many mental disorders, including depressions and psychoses are associated with 
exposure to childhood adversities (CA). One potential pathophysiological pathway from 
CA to symptoms may involve long-term alterations of the Hypothalamic-pituitary-
adrenal axis (HPAA) function leading to measurable differences in steroid outputs 
including cortisol, adrenocortiocotropic hormone (ACTH) and corticotropin releasing 
hormone (CRH) (Herbert, 2012; McEwen, 1998; Wilkinson and Goodyer, 2011). Both 
human and rodent literature suggest that mechanisms modulating cortisol output are in 
part influenced by early rearing factors during infant and childhood periods supporting 
programming effects enduring through to adult life (Meaney et al., 2002; Taylor et al., 
2010; Weaver et al., 2004; Wilkinson and Goodyer, 2011). Attempts to correlate 
variations in HPAA outputs to CA and psychopathology have however yielded 
inconsistent findings within and across psychiatric diagnostic categories (Ciufolini et al., 
2014; Fogelman and Canli, 2018; Young et al., 2000). This has made the formation of 
a robust developmentally sensitive theory of HPAA dysregulation for subsequent 
mental disorders rather problematic. Alterations in HPAA output may also be a 
consequence of dynamic endocrine effects that change with disease state independent 
of any effects of CA - but this has yet to be established.  
 
The last few decades have continued to reveal increasingly complex biological 
mechanisms underpinning HPAA function (Karatsoreos and McEwen, 2011; McEwen, 
2007; Sousa et al., 2008). In general terms, HPAA output can be differentiated into 
tonic (background) and phasic (reactive) components. Tonic cortisol release is also 
subject to diurnal variation regulated by the central circadian clock, a function of the 
hypothalamic suprachiasmatic nucleus (Czeisler et al., 1980; Dickmeis, 2009). In 
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contrast, short-term phasic HPAA activation, such as seen when confronted by novel, 
unexpected or uncontrollable stimuli (Dickerson and Kemeny, 2004), is governed via 
various neural mechanisms involving the prefrontal cortex, limbic and brain stem 
regions including activation in the Locus ceruleus, eventually resulting in cortisol 
secretion. Phasic cortisol response to acute stress has multiple effects on subsequent 
neurophysiological adaptation (allostasis), including the release of energy and shifts of 
cognitive network activation (Danese and McEwen, 2012; Hermans et al., 2011). 
 
In humans, with sleep being a period of relatively low differentiation to environmental 
influences, waking cortisol is considered as marker of baseline tonic output (Bartels et 
al., 2003; Kupper et al., 2005). Support for elevated waking cortisol as trait-like 
biomarker predicting depression has been demonstrated in adolescents (Owens et al., 
2014). While specific mediation through CA exposure was not firmly established, 
heritable mechanisms partly accounted for these findings (Bart et al., 2006; Schreiber 
et al., 2006). 
 
Further, a number of studies have suggested that CA may be associated with individual 
differences in stress related cortisol output (Calhoun et al., 2014; MacMillan et al., 
2009). Compromise of phasic cortisol output (Wilkinson and Goodyer, 2011) may be a 
physiological signature of ineffective adaptive coping (allostatic failure) to current life 
stressors (Danese and McEwen, 2012; de Kloet et al., 2005). However, findings have 
been equivocal with CA predicting both increased (Elzinga et al., 2003; Heim et al., 
2002) and decreased (Calhoun et al., 2014; Carpenter et al., 2007; Elzinga et al., 2008) 
cortisol output under experimental stress in mentally ill participants. 
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Acute cortisol response to stress consists of two components: i) initial increase, 
determined by a cascade of physiological mechanisms, including CRH, ACTH and 
cortisol secretion, and ii) termination of the response (cortisol decrease) which relies on 
efficient negative feedback through glucocorticoid (GR) receptors. Both components 
(increase and decrease) are sensitive to the impact of CA, for example, via interaction 
of early rearing factors with vulnerability genes leading to long-term alterations in the 
control of HPAA output (Mahon et al., 2013; Tyrka et al., 2009; Zannas and Binder, 
2014). For instance, CA has been associated with i) attenuated post-stress cortisol 
decrease via epigenetic alterations of GR receptor sensitivity (Zannas and Binder, 
2014), ii) greater post-stress cortisol increase due to epigenetic influences on CRH 
activation (Tyrka et al., 2009). These effects are considered as independent of each 
other and illustrate two distinct mechanisms accounting for altered post-stress cortisol 
levels in vulnerable individuals.  
 
In summary, components of cortisol output are underpinned by differentiable control 
mechanisms: background diurnal output subserved by the suprachiasmatic nucleus 
and the circadian clock; reactive increase in cortisol, subserved by a neurally sensitive 
cascade system via CRH activation; baseline tonic cortisol levels and post-stress 
cortisol restitution controlled via negative feedback at GR receptors. To date the impact 
of either CA and/or current illness on these components has not been systematically 
differentiated, thus possibly accounting for inconsistent findings.  
 
We conjecture that to better understand the impact of CA on HPAA function in patients 
with mental illnesses requires measuring the following HPAA outputs in a single 
experimental design: tonic waking cortisol (baseline output), diurnal background 
cortisol (non-stress), and both components of phasic cortisol (increase and decrease) 
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in time-environment-matched non-stress and stress conditions. To undertake this 
strategy a multivariate modeling procedure is required that allows for piecewise 
disaggregation of cortisol components when testing for specific associations between 
different cortisol outputs and CA and/or current symptoms. 
 
Based on these considerations we speculate that a history of CA would be associated 
with alterations in HPAA components where programming effects are predicted. In 
contrast, we consider that current symptoms are more likely associated with an overall 
general elevation in daytime cortisol levels. We therefore test the following hypotheses:  
 
1. Greater CA will be associated with elevated waking cortisol levels and 
attenuated post-stress cortisol decrease due to programing effects impairing 
negative feedback mechanisms (Zannas and Binder, 2014). Higher waking 
cortisol likely correlates with impaired post-stress physiological recovery. 
2. Higher symptom scores will be associated with elevated cortisol levels 
across the non-stress condition due to illness related effects such as 
distress (Dienes et al., 2013). 
3. CA may predict greater post-stress cortisol increase in a subgroup, due to 
programing effects on CRH release (Tyrka et al., 2009). 
 
 
In the present study we used a well-validated experimental stress induction paradigm 
(Kirschbaum et al., 1993) measuring post-stress phasic cortisol outputs in a late 
adolescent/young adult (aged 16-25) clinical group at high risk of developing severe 
psychopathology versus age and sex matched controls with no lifetime history of 
mental illness. As cortisol release shows high diurnal variability with different rates of 
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decline throughout the day and also responds to a wide range of internal or external 
triggers, we measured diurnal variation (without induced stress) under equivalent 
environmental conditions at time-matched diurnal times. In addition, we established 
baseline tonic cortisol levels at waking by measuring morning waking cortisol over four 
days prior to experimental procedures. Current symptoms and CA were ascertained via 
questionnaires. We applied updated analytical approaches (see below) to partition out 
the contribution of baseline cortisol and diurnal variation, as well as taking account of 
intra-individual and inter-individual variations of sampling, and timing of peak cortisol 
concentrations. This allows assessing distinct associations of different cortisol outputs 
under waking, non-stress and stressful conditions with CA and current symptoms in 
patients. 
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2. Materials and Methods 
 
We conducted a case-control experiment comparing a Clinical Group (CG) with 
community ascertained Healthy Controls (HC). Three HPAA output components were 
measured: 1) morning waking cortisol, 2) cortisol following stress induction, 3) daytime 
(diurnal) cortisol in a non-stress condition. The latter two were measured on separate 
days at equivalent time-points (details below). The study was approved by the NRES 
East of England committee and was performed in accordance with relevant guidance 
and regulations. 
 
2.1 Participants 
CG (n=20) were recruited from a specialist mental health service for young people 
aged, presenting for the first time with psychotic symptoms, meeting criteria for at-risk 
mental state for psychosis according to the Comprehensive Assessment of At Risk 
Mental States (CAARMS) (Yung et al., 2003), but not for a full psychotic episode 
(Supplementary Information: Full criteria for At-risk mental states). HC (n=21) were 
recruited from a panel of volunteers with no lifetime history of mental illness. All 
participants took part in this study as part of a project investigating the relationship 
between CA, changes in HPAA output, alterations in cognitive performance and 
symptoms in young people at-risk of developing severe psychopathology. Herein we 
report on the characterization of the HPAA profile of the participants.  
 
Psychotic experiences (such as hallucinations) have a relatively high prevalence in 
adolescent/young adult populations (Varghese et al., 2011; Wigman et al., 2012) 
(Kelleher et al., 2012a), but have been found to represent an unspecific symptomatic 
marker of increased risk for developing severe psychopathology with high levels of co-
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morbidity across the spectrum of anxiety, depression and psychotic disorders (Kelleher 
et al., 2012b). Psychotic experiences are also strongly associated with a history of CA 
(Caspi, 2010; Kelleher et al., 2013, 2008). Our clinical group therefore represented 
individuals with a high-risk for developing severe psychopathology and a high 
probability of having experienced CA (Varghese et al., 2011; Wigman et al., 2012). 
Particularily in young populations, symptoms fluctuate and tend to dynamically develop 
across various diagnostic categories over time (Caspi et al., 2014; Cramer et al., 2010). 
Equally, some mood or anxiety related symptoms may be experienced in healthy 
populations without reaching pathological significance or  impairment. Recent research 
suggests that, especially in young populations with emerging mental illness, a 
dimensional approach may be better suited to adequately describe current 
psychopathology (St Clair et al., 2017; Stochl et al., 2015). In the present study, current 
symptoms/clinical status were therefore characterized in four ways; i) determining at-
risk status (CAARMS), ii) determining the current formal categorical DSM IV diagnosis 
via a clinician-led MINI current mental state diagnostic interview (Sheehan et al., 1998), 
iii) determining symptoms dimensionally in relation to depression, delusional thought 
content, and anxiety proneness on continuous scales and, iii) determining level of 
functioning/impairment. Exclusion criteria included habitual smoking, current use of 
antipsychotic medication, steroid medication or contraceptive pill (Supplementary 
Information: Full recruitment procedure, inclusion/exclusion criteria). General cognitive 
functioning (IQ) was established using the Catell culture fair test of intelligence (Cattell, 
1940). 
 
2.2 Procedures  
Participants were telephone screened for eligibility and, if they met criteria, invited for 
an initial interview and written informed consent prior to participation in the study. 
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Participants were given instructions for at-home saliva collection and asked to bring the 
samples to the testing sessions. All testing followed a fixed protocol and timing 
whereby all procedures were conducted at the same times of day. Stress and non-
stress days were counterbalanced according to a pre-set matrix. Dates were set a 
minimum of 2 weeks apart. Prior to each testing session participants were screened for 
compliance with the inclusion criteria. Stress induction was followed by end-of-session 
debriefing.  
 
2.3 Cortisol samples 
2.3.1Waking cortisol  
Patients were instructed to collect saliva upon waking on two days prior to coming to 
each testing session (4 samples in total). A kit with Salivettes (SalimetriCG®) and full 
written instructions were provided (Supplementary Information: Written instructions).  
 
2.3.2 Test days salivary cortisol collection 
Samples were collected at set time points between 12.45 – 14.30 in the laboratory on 
each testing day (TSST: eight sessions; non-stress: six sessions). The stress condition 
consisted of a well validated stress induction procedure (Trier Social Stress Task 
(TSST) (Kirschbaum et al., 1993)). The TSST is a standardized socially evaluative 
stress induction, which includes elements of anticipation (participants are introduced to 
a panel of judges and asked to prepare a presentation for a job interview), public 
speaking (presentation in front of panel) and mental arithmetic (in front of panel). 
Stress induction elicited “TSST cortisol”. The non-stress condition assessed 
background diurnal daytime variation at the time of testing, under controlled laboratory 
conditions (“non-stress cortisol”). To control for mental and physical activity, 
participants were asked to follow instructions of a progressive muscle relaxation tape of 
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equal duration to the TSST. Baseline cortisol was collected prior to either intervention. 
All other samples were collected post-intervention (stress/non-stress) at as close as 
possible matching time points for both conditions. On both days participants performed 
the same set of computer tasks and questionnaires post-intervention whilst collecting 
salivary samples. (Supplementary Information: Figure S1). 
 
The saliva samples were stored in a freezer upon receipt and analyzed at the local 
Core Biochemical Assay Laboratory (CBAL) (Cambridge University Hospitals NHS 
Foundation Trust), using SalimetriCG® Salivary Cortisol Enzyme Immunoassay Kit for 
duplicate cortisol analysis. 
 
All cortisol data were logged in order to minimize the impact of outliers (Hruschka et al., 
2005). 
 
2.4 Symptom scales and Measures for CA 
Current mood symptoms in the whole sample were established with the self-reported 
Beck Depression Inventory BDI (Beck et al., 2006) immediately prior to the stress and 
non-stress sessions, with the mean score being used in analyses. The Peters Delusion 
Inventory (PDI) (Peters et al., 1999) was obtained as a measure of abnormal beliefs 
(appropriate for clinical and non-clinical populations) and the State-Trait-Anxiety 
Inventory (STAI-T) (Spielberger, 2010) was used to ascertain levels of anxiety-
proneness.  Both were obtained once at the beginning of the study, as was the level of 
everyday functioning using the Global Assessment of Functioning (GAF, DSM-IV). CA 
was assessed using the self-reported Childhood Trauma Questionnaire (CTQ) 
(Bernstein et al., 2003). Of the symptom measures, BDI has the greatest established 
clinical validity (Storch et al., 2004). Given that it also was assessed immediately 
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before each testing session, we chose the BDI as the most proximal index of 
symptoms when examining associations between current symptoms and HPAA 
components. 
 
2.5 Data Analysis 
The aims of the data analysis were threefold: first to establish waking cortisol 
characteristics; second to reveal characteristics of the diurnal cortisol in the non-stress 
condition; third to characterize the effects of stress on increase and decrease of cortisol 
levels taking both waking cortisol levels and non-stress (diurnal) levels into account.  
 
Multi-level mixed-effects linear regression using maximum likelihood was performed to 
interrogate the panel cortisol data. Prior studies assessing cortisol reactivity have 
utilized this approach as it accounts for intra-individual variation of baseline (Hruschka 
et al., 2005), missing data, unequally spaced data points (Willett et al., 1998), and non–
independence of repeated measures data (Hruschka et al., 2005). A piecewise 
approach has previously been taken to separate cortisol reactivity and recovery post-
stress, also with a similar sample size to the present study (Hollocks et al., 2014). 
However, here we also account for both waking cortisol and non-stress cortisol, and 
use individual peak cortisol levels instead of group means. 
 
Primary outcomes were waking cortisol, TSST (stress)- and non-stress cortisol. The 
effects of our three key predictors, clinical group (primary predictor), BDI (proximal 
predictor), and CTQ (distal predictor), were assessed in separate models due to high 
correlations among the predictors. In order to effectively test the association of BDI and 
CTQ with cortisol, we pooled HC and CG to allow for a more complete range of BDI and 
CTQ scores, in models where these were predictors. In each model, IQ, age, test day 
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order, gender, and waking cortisol (for TSST and non-stress cortisol outcomes) were 
assessed as fixed-effect confounders; those which were related to both the outcome 
(p<0.1) and predictor (p<0.1 or r/ρ>=0.1) were included in each model. Thus, not all 
confounders will be the same in each model. Repeated measurements were nested 
within individuals (a random-effect). In models predicting waking cortisol, main fixed-
effects of predictors were assessed, along with fixed-effects of day and time of waking, 
and random-effects of time of waking, due to repeated assessments across four days. 
For TSST and non-stress cortisol outcomes, time of measurement was modeled as a 
fixed (linear and quadratic) and random-effect (linear only), as participants’ cortisol 
measurements were not always equally spaced in time (Supplementary Information: 
Table S1). Key predictors (HC/CG, BDI, CTQ) were included in separate models, each 
as a fixed interaction with time to assess the influence of these factors on cortisol’s 
change over time (i.e.: slope). Putative confounders which correlated with these 
predictors were also independently interacted with time on cortisol; those interactions 
which were p<.01 were included in each relevant model. Despite a small sample size, 
we were able to include confounders in the models, as all our models contained well 
over two subjects per variable, the requirement necessary in regression models for 
adequate estimation of regression coefficients, standard errors, and confidence intervals 
(Austin et al, 2015). 
 
 
TSST baseline, peak, and end of the cortisol reaction: The value used for TSST 
baseline cortisol response was obtained immediately prior to the start of the TSST. 
This was an average of 20 minutes (SD=4) after participants arrived in the testing 
room, allowing relaxation after the physical exertion of getting to the appointment. As 
the timing of peak cortisol response varies between individuals (Kirschbaum et al., 
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1993), we assessed which of three theoretically plausible peaks reflected each 
participant’s maximum cortisol output. These peaks were set to be the highest TSST 
cortisol value at a mean of 23 minutes (SD=1), 29 minutes (SD=2), or 36 minutes 
(SD=2) after the start of the task (74). The end of the TSST cortisol reaction was set at 
a mean of 58 minutes (SD=5) after the start of the task, a mean of 22 (SD=2) to 34 
(SD=5) minutes after the peak. To separately model cortisol reactivity increase and 
decrease, the dataset was split into two at the TSST peak cortisol level (varying by 
individual), allowing for piecewise analysis of these phases. 
 
TSST Extreme responders: Given prior reports suggesting that CA is related to overall 
decreased post-stress cortisol but increased cortisol release in a subgroup (Tyrka et 
al., 2009), we explored the sample for potential extreme responders prior to further 
analysis. TSST cortisol slope from start to peak was calculated and inspected for 
outliers.  
 
TSST minus non-stress cortisol: In order to consider TSST cortisol reactivity whilst 
controlling for individual variation in cortisol in the same environment under non-stress 
condition (“non-stress cortisol”), we subtracted logged non-stress cortisol from logged 
TSST cortisol. Prior to this, we accounted for individual variation in the timing of sample 
collection by imputing the non-stress data to the exact time points of the TSST data 
(Supplementary Information: Figure S2). Piecewise multilevel modeling described 
above were repeated with “TSST minus non-stress cortisol” as the outcome.  
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3. Results 
 
3.1 Participant Characteristics 
CG (n=20; 14 male) had a mean age of 20.8 years (SD=2.75) and HC (n=21; 11 males) 
had a mean age of 20.2 (SD=3.25). While all patients were referred due to psychotic 
symptoms, 75% (n=15) met criteria for a diagnosis based on the MINI diagnositic 
interview (Sheehan et al., 1998). Most common primary diagnoses were depressive 
diagnoses (n=8 (40%)), followed by anxiety spectrum diagnoses (n=7 (35%)). As 
expected in this age group, 60% (n=12) also had at least one secondary diagnosis (7 
depressive, 5 anxiety); three met criteria for a third diagnosis. Despite being identified as 
at-risk-mental-state, 5 participants did not meet full criteria for a diagnosis according to 
the MINI, although they exhibited a sufficient range of symptoms and/or impairment in 
functioning to justify inclusion in the clinical group (Figure 1; Supplementary Information: 
Table S2). Eight patients took psychotropic medication, usually SSRIs (Supplementary 
Information: Table S2). As expected, the CG versus HC showed significantly higher 
symptoms, CA, and impairment (Figure 1A and Table 1). CG/HC was collinear with BDI 
and CTQ (rho 0.87 and 0.84 respectively). There was no significant between-group 
difference in IQ (Table 1). Across both groups, in the full dataset, CTQ scores were 
strongly correlated with BDI scores (r=0.63), and BDI was colinear with PDI and STAI 
(r=0.81 and r=.85 respectively). Among those in the clinical group, there were increased 
levels of trait anxiety (STAI-T), psychotic believes (PDI), and depressive symptoms (BDI) 
irrespective of diagnosis. Further, all diagnostic groups showed a mean score of 
depressive symptoms (BDI) above clinical threshold (mild depression). Two HC reported 
below threshold unusual perceptual experiences/unusual thought content on the 
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CAARMS2. There was one HC who exceeded the clinical cut-off for depression on the 
BDI (20), one high outlier on the PDI, and 10 HC with self-reported increased levels 
(>35) of anxiety proness. However these were without associated functional impairment, 
therefore not meeting criteria for a clinical diagnosis. Further, there were 5 HC who had 
experienced moderate or severe CA based on CTQ, and 7 CG who had experienced 
none or low CA, reflecting a range of experiences across the samples. In summary: 
although some mild symptoms were reported in our HC, the CG and HC differed 
significantly on all symptom levels, CA and impairment.  
-------------Insert Figure 1 and Table 1 about here-------------  
 
3.2 TSST exclusions 
One HC was excluded from all TSST analyses due to consistently high and improbable 
cortisol levels throughout the TSST (>3dl, (Salimetrics  Assay range: 0.012. -3.000 
ug/dl, with 3dl representing the ceiling of the test). However, this participant’s data was 
retained in any tonic (morning and non-stress) cortisol analysis as these levels were 
well within range of other HCs. Three CG had extreme responses on the TSST, with 
mean slope 6.5 times greater than all the remaining participants (M=0.88, SD=0.28; 
Supplementary Information: Figure S3), including the HC, and therefore would be 
inappropriate to include. As the extreme responders were clearly too few to analyze 
separately, they were excluded from any TSST analyses, bringing the sample to 17 CG 
and 20 HC. (These individuals’ non-stress cortisol data was normal and therefore was 
used in non-stress analyses). Additionally, one individual’s cortisol did not increase 
                                                 
2
 hypnogogic-hypnopmpic experiences/occasional feeling that others look or talk about the 
subject) 
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during the TSST; these data were used for cortisol increase, but cortisol decrease was 
not calculated due to no prior increase. 
 
3.3 Waking cortisol 
Waking cortisol was not significantly different between the four sampling days, nor did 
time of waking influence cortisol as a fixed-effect. However, inclusion of time of waking 
as a random-effect improved model fit (Akaike information criterion decreased) and 
thus was included in all models with waking cortisol as outcome. One HC participant 
was missing waking cortisol data. Only CTQ was positively associated with waking 
cortisol; no association was found with HC/CG or depressive symptoms (Table 2). 
Waking cortisol was also assessed as a predictor of non-stress and “TSST minus non-
stress cortisol", with confounds included as described in methods. Waking cortisol did 
not influence non-stress cortisol decline (i.e.: no interaction with time: linear p=0.59, 
quadratic p=0.49) or non-stress cortisol levels across the whole testing period (p=0.79). 
Additionally, waking cortisol did not influence slope increase or decrease in the “TSST 
minus non-stress” condition, but it did yield a positive influence on overall cortisol 
values from TSST peak to finish (Figure 2). 
 
-------------Insert Table 2 and Figure 2 about here------------- 
 
3.4 Cortisol under Non-stress Condition 
There was a significant diurnal decline of cortisol over time (linearly: Coef=-0.26x10-2 (-
0.49x10-2 to -0.02x10-2), p=0.033; quadratically: Coef=-6.25 x 10-5 (-11.90x10-5 to -
0.60x10-5), p=.030). None of the predictors influenced this slope. CG versus HC and 
BDI scores were positively associated with higher overall cortisol across all time points 
(Figure 3).  
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-------------Insert Figure 3 about here------------- 
 
3.5 Cortisol and TSST condition 
Piecewise analysis of “TSST minus non-stress cortisol” revealed linear but not 
quadratic effects of time in the increase (baseline to peak) and decrease (peak to end) 
phase (Supplemental Information: Table S3) Therefore only interactions with time (not 
time2) were assessed. An attenuated cortisol increase was noted in CG compared with 
HC, which was a trend level for cortisol decrease (Figure 4A). Higher BDI scores 
attenuated cortisol increase (Figure 4C), and higher CTQ scores attenuated cortisol 
decrease (Figure 4B). Findings with “TSST minus non-stress cortisol” differed from 
TSST uncontrolled for diurnal cortisol. TSST cortisol uncontrolled by non-stress cortisol 
showed CG, CTQ, and BDI had no effect on cortisol increase but all attenuated cortisol 
decrease (Supplementary Information: Table S4).  
 
-------------Insert Figure 4 about here-------------  
 
In summary, a differential pattern of predictors of the differential aspects of cortisol 
output emerges: 
i) Higher CTQ scores were associated with elevated morning cortisol levels.  
ii) BDI scores were associated with overall elevated cortisol in the non-stress condition.  
iii) In the stress condition (controlling for the non-stress cortisol levels) current 
depressive symptoms were associated with attenuated cortisol increase. Conversely, 
higher CTQ scores were associated with attenuated cortisol decrease. 
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4. Discussion 
 
While both HPAA and CA have been related to various types of psychopathology, 
correlations within and across psychiatric diagnostic categories have been inconsistent 
(Ciufolini et al., 2014; Fogelman and Canli, 2018; Young et al., 2000). Recently it has 
been suggested that new approaches may be nessecary to tackle heterogeneity in 
findings of HPAA outputs in relation to CA and psychopatology (Fogelman and Canli, 
2018). Within the present study, we set out to systematically disaggregate the 
associations between current depressive symptoms and self-reported CA with 
components of HPAA output in participants at-risk to developing severe 
psychopathology (CG) and HC with no lifetime history of mental illness. We chose this 
strategy because of potentially distinct underlying latent mechanisms governing waking 
cortisol levels, diurnal decline and components of phasic cortisol response (increase 
and decrease) that may be differentially susceptible to exposure to CA and/or current 
symptoms. We hypothesized that CA and current illness would show different 
associations with distinct components of HPAA output. In order to test this, we needed 
to disaggregate the phasic response to stress into its physiological components of 
increase and subsequent decrease, distinguish high from low responders, control for 
baseline tonic output at waking and partition out the alterations in non-stress diurnal 
cortisol output at the same time of day. 
 
Consistent with our first hypothesis, we revealed that elevated tonic waking cortisol 
was associated specifically with higher CTQ scores regardless of group (case-control). 
Furthermore, higher CTQ scores were also specifically associated with attenuated 
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phasic post-stress cortisol decrease. Elevated waking cortisol correlated with higher 
post-peak cortisol after stress induction. 
 
Given the small sample size and lack of genetic data to control for genetic effects on 
morning waking cortisol levels or post-stress decrease, we cannot make definite claims 
regarding the precise mechanism underpinning these effects. However, CA related, 
epigenetically determined downregulation in GR sensitivity, with successive 
impairments in negative feedback mechanisms may provide one possible explanation 
for the association between CA, elevated waking cortisol as marker of increased 
baseline tonic output, and attenuated post-stress recovery, independent of symptom 
related effects. Our findings are theoretically consistent with developmental 
programming effects following CA exposure, which only affect distinct components in 
HPAA output in vulnerable populations, but  are potentially related to long term risk of 
successive severe psychopathology. If confirmed in future studies this provides a 
potential explanatory framework for morning waking cortisol acting as a biomarker 
amongst the adolescent ‘at risk’ population for major depression (Owens et al., 2014), 
that is explained by both heritable mechanisms and CA.  
 
In contrast, cortisol levels measured during the non-stress condition were positively 
associated only with symptom scores of current depression, suggesting that, the more 
severe the illness profile the greater the likelihood of an overall elevated diurnal cortisol 
output. The results are consistent with our second hypothesis and support an 
independent effect of current symptoms on parameters of HPAA output, irrespective of 
CA. These latter results resonate with studies noting that a proportion of currently 
depressed patients show a reversible loss of day and nighttime diurnal rhythm in their 
HPAA function, and this may be more likely in the most severely ill patients (Binder et 
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al., 2004). To our knowledge, this is the first study specifically assessing diurnal 
variation at time-matched intervals to the stress related phasic response. The above 
findings strongly support our methodological approach of controlling for non-stress 
characteristics of the HPAA output in order to systematically disaggregate the impacts 
of CA and current symptoms respectively when investigating HPAA phasic response to 
stress in patients. 
 
In addition, we noted that greater depressive symptoms correlated with attenuated 
post-stress phasic cortisol increase. We hypothesized that perhaps during illness, 
already increased daytime diurnal HPAA output may limit the physiological reserve for 
adaptive (allostatic) post-stress cortisol increase.  
 
Previous clinical studies have suggested both an increased and attenuated phasic 
cortisol response to acute stress in populations with CA and mental illness (Calhoun et 
al., 2014; Carpenter et al., 2007; Elzinga et al., 2008, 2003; Heim et al., 2002). In line 
with our third hypothesis we identified a small subgroup of clinical participants showing 
extreme cortisol reactivity. The theoretical approach to analyses in this study is guided  
by understanding of the biological underpinnings of cortisol realease to date. On this 
basis, excluding these from the rest of the sample was justified: based on previous 
literature, they likely represent a further physiologically distinct clinical subgroup related 
to gene-by-environment mechanisms affecting CRH control (Bradley et al., 2008; Tyrka 
et al., 2009). Future studies with larger sample sizes might be able to further explore 
CA/illness related associations in such subgroups. 
 
To date findings of HPAA abnormalities have been inconsistent within or across 
diagnostic categories. Co-morbidity in DSM IV diagnoses was common in our sample. 
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This was expected as the CG was recruited based on psychotic symptoms, as marker 
for high-risk of emerging severe psychopathology (Kelleher et al., 2012b) and related to 
high levels of co-morbidity in young populations. Therefore, and in recognition of 
increasing calls for dimentional definitions of mental health in research (Caspi et al., 
2014; Krueger et al., 1998) we chose a dimensional approach to characterizing current 
psychopathology across several symptom domains of depression, anxiety and 
abnormal beliefs. This also allowed pooling data across samples for some of the 
analyses. Despite the categorical diagnostic hereogeneity within the CG, higher levels 
of symptoms in all domains were seen in CG versus HC, irrespective of CG diagnosis. 
The symptom profile of our group resonates with the increasing recognition that 
diagnostic categories represent less distinct pathologies than previously thought, but 
overlapping symptom clusters (Cramer et al., 2010), with a potentially common latent 
factor underpinning mood, anxiety and psychotic disorders (Stochl et al., 2015). CA 
and HPAA abnormalities are associated with many mental illnesses. CA related 
programming effects on physiological changes may be present irrespective of the 
dynamic effects of current symptom status (Faravelli et al., 2010), and possibly 
represent a latent mechanism common to these symptom clusters. 
  
Stress induction in clinical populations is notoriously difficult to conduct due to primary 
and secondary contraindications of inflicting stress upon an unwell population. 
Therefore most current data rely on sub-clinical population studies or small numbers in 
clinical groups (Heim et al., 2002; Hollocks et al., 2014; Young et al., 2000). Clearly, 
conclusions of this study are limited by its small sample size and replication is needed 
in larger sample sizes using similar methodology. For example, larger sample sizes 
would allow for assessment of cortisol profiles separately by clinical status and/or 
gender. However, to our knowledge this is the first study employing piecewise 
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multilevel modeling to fully disaggregate different physiological components of the 
phasic HPAA response in mentally ill patients. By using this approach, we maximize 
the power of a small data set over 2 experimental days (stress and non-stress). We 
also provide a proof-of-principle for the importance of this statistical disaggregation by 
revealing putatively different effects on tonic, diurnal and phasic cortisol outputs and 
further demonstrate the importance of controlling for the non-stress diurnal levels in 
such populations.  
 
Theoretically, distinguishing physiological subgroups is of value in preparation for 
delineating developmental pathways resulting from the impact of CA. For example, CA 
has been theorized to evoke specific changes in HPAA function, and putative 
subsequent downstream developmental events (Cicchetti, 2010), with specific 
influence on neurocognitive processes (Diamond et al., 2007; Lupien et al., 2007). 
Indeed, high waking cortisol levels have been associated with overgeneralized 
autobiographic memories (Owens et al., 2014). Future developmental theories of 
HPAA dysregulation in the pathogenesis of mental disorders could benefit from 
accounting for the heterogeneity of cortisol profiles (Fogelman and Canli, 2018; Hagan 
et al., 2015).  
 
5. Conclusions 
Herein we present a novel approach to cortisol analysis which systematically 
disaggregates components of HPAA output. Such analysis has allowed us to 
distinguish effects of CA and current depressive symptoms on cortisol levels in young 
people at high-risk for developing severe mental illness. Our findings provide 
preliminary novel evidence for a differential HPAA axis dysregulation hypothesis 
regarding the impact of CA and current depressive symptoms on specific components 
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of HPAA output. We suggest that the elevated waking cortisol and attenuated cortisol 
decrease post-stress in this population likely reflects negative glucocorticoid feedback 
as a result of programing effects via an interaction of CA with vulnerability genes, 
rather than being directly symptom related. Impaired negative GR feedback has been 
associated with various disorders, including depression and psychcosis (Zannas and 
Binder, 2014). Consistent with the clinical presentation of our sample (multiple, mixed 
symptoms, high prevalence of CA) our sample might represent a subgroup of youth at-
risk of a more severe course of illness, greater treatment resistance, and lifelong risk of 
for recurrent illness. Future studies will need to establish the programing effect of CA 
vesus later life adversity. During illness, elevated daytime cortisol output may deplete 
cortisol reserves and further compromise the capacity for adaptive physiological 
responsiveness to current stress, and thus contribute to maintenance of symptom 
levels. These conclusions are clearly tentative due to several limitations of the study, 
including the sample size limiting subgroup-analyses. Future studies will need to 
replicate and extend these findings with larger sample sizes. However, the proposed 
methodology in this proof-of-principle study provides a tool for the differentiation of 
distinct, biologically plausible subgroups.  
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Dobler & Neufeld et al 
 
 
28 
Table 1 
Title: Participant Characteristics 
 Combined 
mean (SD) 
n HC mean 
(SD) 
n CG mean 
(SD) 
n t-test p 
BDIa 14.43 
(13.15) 
41 5.13 (5.21) 21 24.20 (11.81) 20 -6.75 < 0.0001 
PDI 8.78 (9.20) 40 3.38 (5.19) 21 14.74 (9.05) 19 -4.93 < 0.0001 
CTQ 41.88 
(17.98) 
40 31.05 (4.41) 20 52.70 (19.93) 20 -4.74 < 0.0001 
STAI-T 47.71 
(14.28) 
41 37.52 (8.85) 21 58.40 (10.58) 20 -6.87 < 0.0001 
GAF 65.55 
(22.40) 
33 86.53 (3.91) 17 43.25 (4.97) 16 27.89 < 0.0001 
IQ 117.29 
(17.80) 
41 121.33 
(18.11) 
21 113.05 
(16.87) 
20 1.51 0.14 
 
a mean of scores taken prior to each testing day.  
 
Table 2  
Title: Waking cortisol  
 
(A) Distal and proximal influences on waking cortisola 
Effect Nb Coef 95% CI p 
Main Effects 
    
   Day 151 (39) -4.87 x 10-2 -13.42 x 10-2 to 3.68 x 10-2 0.26 
   Time of waking 151 (39) -0.07 x 10-2 -0.29 x 10-2 to 0.15 x 10-2 0.52 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Dobler & Neufeld et al 
 
 
29 
   HC/CG (1=CG) 143 (37) 6.37 x 10-2 -26.02 x 10-2 to 38.75 x 10-2 0.70 
   CTQ  147 (38) 0.92 x 10-2 0.36 x 10-2 to 1.49 x 10-2  0.001 
   BDI 151 (39) 0.42 x 10-2 -1.24 x 10-2 to 2.08 x 10-2 0.62 
 
 
a
 Multilevel model across 4 days. Only the CTQ model required adjustment for confounding 
(gender was included). All models include random effects of time of waking (missing in 1 
individual), but findings remain when this random effect is not included. 
b
 bracketed number refers to the number of cases.  Waking cortisol was missing from one HC 
participant, and time of waking was missing for another.  CTQ was missing from an additional 
participant. HC/CG analyses excluded two participants who were outliers on BDI or PDI.  
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Table and Figure Legends 
 
Table 1 
 
Title 
Participant Characteristics 
 
Legend 
HC=healthy controls; CG=clinical group; BDI=Beck Depression Inventory; PDI=Peters 
Delusion Inventory; STAI-T=State-Trait-Anxiety Inventory (Trait Anxiety); GAF=Global 
Assessment of Functioning; IQ=General cognitive functioning 
 
Table 2   
 
Title  
Waking cortisol 
 
Legend 
Waking cortisol levels were not influenced by HC/CG, but they were associated with 
increased CTQ scores. 
 
Figure 1 
Title 
Symptom characteristics (A) and impairment (B) within diagnostic categories in Clinical 
Group (CG) and Healthy Controls (HC) 
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Legend 
A: Cumulative scores in self-rated questionnaires on delusional thought content (PDI), 
anxiety proness (STAI-T) and depression (mean BDI) in HC and CG (N=no diagnosis, 
A=anxiety spectrum, D=depression). While some sypmptoms were present in the HC 
with no lifetime history of mental illness, in the CG all symptom scales were 
significantly elevated.  
B: In comparison to the HC the CG was functionally impared according to the GAF. 
 
 
Figure 2 
 
Title 
Predictive marginsb of waking cortisol on “TSST minus non-stress cortisol” increase 
and decrease (TSST=Trier Social Stress Test), adjusted by confounds. 
 
Legend 
Piecewise analysis of cases and controls together revealed that waking cortisol levels 
did not influence “TSST minus non-stress cortisol” increase (Coef= 0.32x10-2 (95% CI: -
0.73x10-2, 1.36x10-2), p=0.55; confound: gender x time) or decrease (Coef=0.49x10-2 (-
0.54x10-2, 1.53x10-2), p=0.35; confounds: age x time, gender). However, waking 
cortisol had a positive influence on overall “TSST minus non-stress cortisol” levels, 
non-significant from TSST start to peak (Coef=0.21 (-0.02, 0.43), p=0.074; confound: 
gender), but significant from TSST peak to finish (Coef=0.34 (0.03, 0.65), p=0.031; 
confound: gender). Sample size: Four TSST ouliers were excluded (see method and 
results). Waking cortisol was missing from one participant. The decline phase 
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additionally excluded one participant who exhibited no cortisol increase from the TSST. 
All TSST slope increase and decrease models have 3 to 5 timepoints per person, 
which varies depending on when each individual peak occurred. This resulted in n=132 
(36 participants) for analyses of cortisol increase, and n=151 (35 participants) for 
cortisol decrease.  
 
 
Figure 3 
 
Title 
Influence of predictors on non-stress cortisol, adjusted by confounds 
 
Legend 
Predictors did not influence non-stress cortisol slope (all interactions with time and 
time2, p>=0.36). Therefore main effects of predictors are presented, adjusted for 
confounding, and including the quadratic effect of time. 95% Confidence intervals are 
from the standard error of prediction. Continuous predictors were divided into quartiles 
to depict their influence on non-stress cortisol. A) The clinical group (CG) exhibited 
higher levels of non-stress cortisol than the healthy controls (HC) throughout the testing 
period (Coef=0.47, (0.19, 0.75), p=0.001; confound: gender; n=236 [41 participants x 6 
timepoints.]). B) Across the whole sample, CTQ scores did not influence non-stress 
cortisol levels (Coef=0.34x10-2 (-0.45x10-2, 1.13x10-2), p=0.40); confounds: gender, IQ; 
n=240 [40 participants x 6 timepoints. One participant was missing CTQ]). C) Across 
the whole sample, those with higher BDI scores had higher levels of non-stress cortisol 
throughout the testing period (Coef=1.11x10-2 (0.33x10-2, 1.89x10-2), p=0.005; 
confounds: IQ, test day order; n=246 [41 participants x 6 timepoints]).  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Dobler & Neufeld et al 
 
 
49 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Dobler & Neufeld et al 
 
 
50 
 
Figure 4 
 
Title 
Influence of predictors on “TSST minus non-stress cortisol” increase and decrease, 
adjusted by confounds 
 
Legend 
Predictive marginsb are used in B and C to show the influence of a continuous predictor 
on cortisol slope. A) The clinical group (CG) exhibited an attenuated increase (Coef=-
10.57x10-3 (95% CI: -19.92x10-3, -1.21x10-3), p=0.027) and trend level decrease 
(Coef=9.56x10-3 (1.27x10-3, 20.38x10-3), p=0.084) in cortisol compared with healthy 
controls (HC), as shown by significant interactions of HC/CG with time. B) Across the 
whole sample, CTQ scores did not influence cortisol increase (p=0.51; full statistics 
presented in Table S3) but higher CTQ scores attenuated cortisol decrease 
(Coef=0.31x10-3 (0.03x10-3, 0.59x10-3), p=0.028). C) In the whole sample, higher BDI 
scores attenuated cortisol increase (Coef=-0.41x10-3 (-0.76x10-3, -0.05x10-3), p=0.025) 
but not decrease (p=0.15). (See Table S3 for confounds and sample size; TSST=Trier 
Social Stress Test). 
 
 
bFor depicting effects of continuous predictors (CTQ and BDI) on “TSST minus non-stress 
cortisol”, predictive margins were computed from each model at the mean of the predictor, and 
+/-1SD from the mean. (Predictive margins are computed probabilies of the outcome at 
specified values for the independent variable in the model.  
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Highlights 
 
• Update of cortisol analysis  
• Disaggregation of biological components of HPA axis output 
• Associations of early adversity and/or illness are tested for each 
component 
• Early adversity relates to high waking cortisol and attenuated post-
stress recovery 
• Current symptoms relate to high daytime cortisol and less adaptive 
cortisol release 
 
